Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5502)
Arcutis Biotherapeutics, Inc. (ARQT)
LIN SUE-JEAN — Director
Shares
4,946
Price
$24.38
Total Value
$120.59K
Shares Held After
27,567
% of Holdings
15.2%
Stablecoin Development Corp (SDEV)
Kazley Michael John — Director
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
Framework Ventures IV L.P. — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Stablecoin Development Corp (SDEV)
R01 Fund LP — 10% Owner
Shares
24,720
Price
$1.09
Total Value
$26.94K
Shares Held After
22,668,516
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
100,000
Price
$17.37
Total Value
$1.74M
Shares Held After
1,412,058
% of Holdings
6.6%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
60,400
Price
$160.17
Total Value
$9.67M
Shares Held After
158,222
% of Holdings
27.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
6,657
Price
$16.39
Total Value
$109.08K
Shares Held After
232,457
% of Holdings
2.8%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,328
Price
$16.38
Total Value
$54.53K
Shares Held After
239,114
% of Holdings
1.4%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
3,329
Price
$16.39
Total Value
$54.56K
Shares Held After
242,442
% of Holdings
1.4%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
272,322
Price
$45.02
Total Value
$12.26M
Shares Held After
7,388,902
% of Holdings
3.6%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
9,086
Price
$45.02
Total Value
$409.05K
Shares Held After
245,728
% of Holdings
3.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,538
Price
$60.71
Total Value
$336.21K
Shares Held After
15,437
% of Holdings
26.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
DAVITA INC. (DVA)
Waters Kathleen Alyce — Chief Legal & Pub. Affairs Off
Shares
6,455
Price
$209.17
Total Value
$1.35M
Shares Held After
109,194
% of Holdings
5.6%
DAVITA INC. (DVA)
Waters Kathleen Alyce — Chief Legal & Pub. Affairs Off
Shares
8,950
Price
$207.84
Total Value
$1.86M
Shares Held After
115,649
% of Holdings
7.2%
DAVITA INC. (DVA)
Rodriguez Javier — Director
Shares
30,000
Price
$209.50
Total Value
$6.29M
Shares Held After
879,815
% of Holdings
3.3%
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
1,624
Price
$3.05
Total Value
$4.95K
Shares Held After
295,324
% of Holdings
0.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
100
Price
$31.46
Total Value
$3.15K
Shares Held After
135,209
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,191
Price
$31.05
Total Value
$68.03K
Shares Held After
135,309
% of Holdings
1.6%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — Senior Vice President of Laboratory Operations
Shares
1,416
Price
$101.47
Total Value
$143.68K
Shares Held After
34,968
% of Holdings
3.9%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — Senior Vice President of Laboratory Operations
Shares
1,416
Price
$101.47
Total Value
$143.68K
Shares Held After
36,384
% of Holdings
3.7%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
563
Price
$104.32
Total Value
$58.73K
Shares Held After
1,000
% of Holdings
36.0%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,398
Price
$103.63
Total Value
$248.50K
Shares Held After
1,563
% of Holdings
60.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,978
Price
$102.60
Total Value
$305.54K
Shares Held After
3,961
% of Holdings
42.9%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,461
Price
$101.37
Total Value
$249.47K
Shares Held After
6,939
% of Holdings
26.2%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
1,000
Price
$100.05
Total Value
$100.05K
Shares Held After
9,400
% of Holdings
9.6%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
600
Price
$98.74
Total Value
$59.25K
Shares Held After
10,400
% of Holdings
5.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
230
Price
$104.47
Total Value
$24.03K
Shares Held After
11,000
% of Holdings
2.0%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,889
Price
$103.68
Total Value
$299.54K
Shares Held After
11,230
% of Holdings
20.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,816
Price
$102.77
Total Value
$289.41K
Shares Held After
14,119
% of Holdings
16.6%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,361
Price
$101.55
Total Value
$239.77K
Shares Held After
16,935
% of Holdings
12.2%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
1,704
Price
$100.37
Total Value
$171.03K
Shares Held After
19,296
% of Holdings
8.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.66
Total Value
$5.74K
Shares Held After
12,646
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.66
Total Value
$5.74K
Shares Held After
12,646
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.66
Total Value
$5.74K
Shares Held After
12,646
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.66
Total Value
$5.74K
Shares Held After
12,646
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,153
Price
$20.66
Total Value
$23.82K
Shares Held After
35,755
% of Holdings
3.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,357
Price
$20.66
Total Value
$28.04K
Shares Held After
42,067
% of Holdings
3.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
550
Price
$20.66
Total Value
$11.36K
Shares Held After
21,479
% of Holdings
2.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Porter Derrell — Director
Shares
6,460
Price
$2.35
Total Value
$15.15K
Shares Held After
48,300
% of Holdings
11.8%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$51.37
Total Value
$2.74M
Shares Held After
1,483,848
% of Holdings
3.5%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
59
Price
$27.94
Total Value
$1.65K
Shares Held After
81,600
% of Holdings
0.1%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
224
Price
$27.12
Total Value
$6.08K
Shares Held After
81,659
% of Holdings
0.3%
LivaNova PLC (LIVN)
Bianchi Francesco — Director
Shares
1,200
Price
$80.19
Total Value
$96.23K
Shares Held After
9,584
% of Holdings
11.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
4,062
Price
$450.00
Total Value
$1.83M
Shares Held After
16,953
% of Holdings
19.3%
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
60,000
Price
$18.23
Total Value
$1.09M
Shares Held After
54,037
% of Holdings
52.6%
Ocugen, Inc. (OCGN)
Johnson-Greene Treerita Essalima — Chief Financial Officer
Shares
21,000
Price
$1.23
Total Value
$25.83K
Shares Held After
521,000
% of Holdings
4.0%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
3,183
Price
$3.32
Total Value
$10.57K
Shares Held After
103,492
% of Holdings
3.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.19
Total Value
$10.19K
Shares Held After
17,592
% of Holdings
5.7%
TransMedics Group, Inc. (TMDX)
Gunderson Thomas J. — Director
Shares
9,624
Price
$75.06
Total Value
$722.38K
Shares Held After
16,642
% of Holdings
36.6%
Showing 151–200 of 5502 transactions (page 4 of 111)